NOT-CA-20-059: Pre-Application Webinar for RFA-CA-20-030, Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed)

Pre-Application Webinar for RFA-CA-20-030, Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed)

Notice Number:

NOT-CA-20-059

Key Dates

Release Date:

April 27, 2020

Related Announcements

RFA-CA-20-030 Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The NCI will hold a pre-application webinar on Friday, May 8, 2020, from 1:00 - 2:00 PM (ET) for the Funding Opportunity Announcement (FOA) RFA-CA-20-030 entitled "Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed).

NCI staff members involved in the FOA will provide a brief overview of the above-referenced FOA for potential applicants by explaining the goals and objectives for the FOA, as well as answering questions from webinar attendees.

Please submit questions by May 6, 2020 to [email protected]. Attendees will also be able to submit questions during the webinar. Questions submitted early will be answered first.

Join the webinar, or copy and paste the following Webex link into your browser: https://cbiit.webex.com/cbiit/onstage/g.php?MTID=e10b31a1cf38a2319333057fcc383a571

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-20-030. A document highlighting frequently asked questions and corresponding answers will be posted to the EGRP website following the webinar.

Inquiries

Please direct all inquiries to:

Joanne Elena, Ph.D., M.P.H.,
National Cancer Institute (NCI)
Telephone: 240-276-6818
Email: [email protected]